GlaxoSmithKline PLC News Headlines

GSK 
$52.51
*  
0.31
 negative 
0.59%
Get GSK Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    GSK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Evoke Pharma Moves Full Speed Ahead
1/26/2014 7:46:00 PM - Seeking Alpha

Big Pharmas Battle For The Billion-Dollar Melanoma Market
1/24/2014 6:42:00 PM - Seeking Alpha

GSK Gets Positive CHMP Opinion For Eperzan To Treat Type 2 Diabetes
1/24/2014 8:33:00 AM - RTT News

GSK Reports Results For Late-stage Study Of Combination Of Tafinlar And Mekinist
1/24/2014 8:16:00 AM - RTT News

Tweedy Browne Global Value Fund New Buy and Adds
1/23/2014 4:51:56 PM - GuruFocus

More Great Dividend Stocks From Great Britain
1/23/2014 6:29:00 AM - Seeking Alpha

GSK: ViiV Healthcare's New HIV Drug Tivicay Approved in Europe
1/21/2014 7:29:00 AM - Dow Jones Business News

ViiV Healthcare: European Commission Approves Tivicay In Treatment Of HIV
1/21/2014 7:09:00 AM - RTT News

Actavis Joins the Divestment Bandwagon - Analyst Blog
1/20/2014 6:55:01 PM - Zacks.com

Great Dividend Growth Stocks From United Kingdom
1/20/2014 10:17:00 AM - Seeking Alpha

China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies
1/19/2014 2:07:00 AM - Seeking Alpha

Amicus Update on Strategy, Guidance - Analyst Blog
1/17/2014 6:49:01 PM - Zacks.com

Carlyle Group Offers to Buy JNJ's OCD Biz - Analyst Blog
1/17/2014 6:00:01 PM - Zacks.com

AstraZeneca: Should You Buy This 4.5% Yielder?
1/16/2014 11:56:00 AM - Seeking Alpha

Update on Glaxo's Oncology Pipeline - Analyst Blog
1/13/2014 1:20:01 PM - Zacks.com

Bluebird Bio: 5 Different Insiders Have Sold Shares During The Last 30 Days
1/13/2014 12:31:00 PM - Seeking Alpha

AstraZeneca's Farxiga Gets FDA Nod - Analyst Blog
1/9/2014 6:00:01 PM - Zacks.com

Eli Lilly Shares down Slightly on Guidance - Analyst Blog
1/9/2014 2:40:01 PM - Zacks.com

Epizyme Up on Milestone Payments - Analyst Blog
1/8/2014 1:10:01 PM - Zacks.com

Pharmacyclics Soars on Positive Imbruvica News - Analyst Blog
1/8/2014 12:40:01 PM - Zacks.com

Pick GlaxoSmithKline For A Sustainable 4.6% Yield
1/7/2014 6:50:00 PM - Seeking Alpha

Exelixis Has A Stellar Year Ahead
1/6/2014 5:21:00 PM - Seeking Alpha

Amicus Therapeutics Raises Funds - Analyst Blog
1/2/2014 5:55:01 PM - Zacks.com

Glaxo Divests Certain Assets - Analyst Blog
1/2/2014 1:50:01 PM - Zacks.com

Which ADRs Are The Most Widely Held?
1/2/2014 5:17:00 AM - Seeking Alpha